Author

Amanda Riley

Kent State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alice H. BergeriD· 1 shared Athea Vichas· 1 shared Emily M. Hatch· 1 shared Federica PiccioniiD· 1 shared Fujiko Duke· 1 shared Hannah LeeiD· 1 shared Iris Fung· 1 shared Jacqueline Watson· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice H. BergerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Changes to Astrocyte-associated Protein Expression at Different Timepoints of Cuprizone Treatment

Lana Frankle, Amanda Riley, Riely Tomor, Hannah Lee, Kole Jarzembak, Olesia Benedict, Sarah Sternbach, John Shelestak, Jennifer Ann McDonough, Robert John Clements

The paper measures changes in astrocyte-associated protein expression at different timepoints during cuprizone treatment, finding non-linear increases in A1 and A2 markers.

bioRxiv · Apr 20, 2023 · PreprintNeuroscience

An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer

Athea Vichas, Naomi T. Nkinsi, Amanda Riley, Phoebe C.R. Parrish, Fujiko Duke, Jenny Chen, Iris Fung, Jacqueline Watson, Matthew Rees, John K. Lee, Federica Piccioni, Emily M. Hatch, Alice H. Berger

This study identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer through integrative analysis of CRISPR screens and drug sensitivity data.

bioRxiv · Jul 3, 2020Cancer Biology